Form 4: Nutex Health CEO Thomas Vo Acquires 150,000 Restricted Stock Units
SEC Form 4 Filing
Nutex Health's CEO, Thomas Vo, was granted 150,000 Restricted Stock Units (RSUs) that will vest in three equal installments.
Summary
- On June 28, 2024, Thomas T. Vo, CEO of Nutex Health, Inc., was granted 150,000 Restricted Stock Units (RSUs).
- Each RSU represents a contingent right to receive one share of Nutex Health's common stock.
- The RSUs will vest in three equal installments on March 1, 2025, March 1, 2026, and March 1, 2027, according to the Restricted Stock Unit Agreement.
Sentiment
Score: 7
Explanation: The grant of RSUs is a positive sign, indicating confidence in the company's future performance and aligning management's interests with shareholders.
Positives
- The grant of RSUs to the CEO aligns his interests with those of the shareholders, incentivizing him to improve the company's performance.
Future Outlook
The vesting schedule of the RSUs suggests a long-term commitment from the CEO to the company's success.
Industry Context
Granting RSUs to executives is a common practice in the healthcare industry to incentivize performance and retain key personnel.
Stakeholder Impact
- Shareholders may view the RSU grant positively as it aligns the CEO's interests with theirs.
- Employees may see the grant as a sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 06/28/2024 | Date of transaction: Thomas T. Vo was granted 150,000 Restricted Stock Units. |
| 03/01/2025 | First vesting date: 1/3 of the RSUs (50,000) will vest. |
| 03/01/2026 | Second vesting date: 1/3 of the RSUs (50,000) will vest. |
| 03/01/2027 | Third vesting date: 1/3 of the RSUs (50,000) will vest. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.